Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Prot #CLTR0310-301: PHASE III, MULTICENTER, RANDOMIZED, TRIAL OF CPX-351 (CYTARABINE: DAUNORUBICIN) LIPOSOME INJECTION VERSUS CYTARABINE AND DAUNORUBICIN IN PATIENTS 60-75 YEARS OF AGE WITH UNTREATED HIGH RISK (SECONDARY) AML
Frankfurt, Olga
(PD/PI)
Medicine, Hematology Oncology Division
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
2/19/13
→
2/19/21
Funding
Celator Pharmaceuticals, Inc.
(Prot #CLTR0310-301)
View all
View less